TY  - GEN
AU  - Moro,Ruth N
AU  - Scott,Nigel A
AU  - Vernon,Andrew
AU  - Tepper,Naomi K
AU  - Goldberg,Stefan V
AU  - Schwartzman,Kevin
AU  - Leung,Chi-Chiu
AU  - Schluger,Neil W
AU  - Belknap,Robert W
AU  - Chaisson,Richard E
AU  - Narita,Masahiro
AU  - Machado,Elizabeth S
AU  - Lopez,Marta
AU  - Sanchez,Jorge
AU  - Villarino,Margarita E
AU  - Sterling,Timothy R
TI  - Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials
SN  - 2325-6621
PY  - 2019///1028
KW  - Adolescent
KW  - Adult
KW  - Antitubercular Agents
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Infant, Newborn
KW  - Isoniazid
KW  - Latent Tuberculosis
KW  - drug therapy
KW  - Middle Aged
KW  - Pregnancy
KW  - Pregnancy Complications, Infectious
KW  - Pregnancy Outcome
KW  - Rifampin
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1513/AnnalsATS.201704-326OC
ER  -